A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Recruiting · NCT06131840 · Registry updated 2026-07-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, gastric neoplasm, gastroesophageal junction adenocarcinoma, intestinal disorder, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, pancreatic ductal adenocarcinoma, rectal disorder, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma, stomach disorder | Recruiting | Phase 1 | 2026-07-22 | NCT06131840 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sanofi | 254 |
| Seagen, a wholly owned subsidiary of Pfizer | 16 |
48 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.